LIVE FROM THE DATABASETRANSACTIONS 723,671COMPANIES 6,572LATEST TRADE Oct 27UPDATED Oct 28, 12:45 PM
Reporting ownerCIK 0002023489

Troy Lister

13 transactions in one company, from January 8, 2025 to July 25, 2025.

Transactions
131 company
Bought · P
$0open market
Sold · S
$9Kopen market
Net
−$9Knet selling

By company

Where this insider traded.

CompanyTickerTradesBoughtSold
Verve Therapeutics, Inc.VERV13—$9K

All transactions

13 in total, newest filings first.

CompanyTickerInsiderDateCodeSharesPriceValueHeld after
Verve Therapeutics, Inc.VERVTroy ListerChiefDERIVJul 25DReturned to issuer69,500——0derivatives
Verve Therapeutics, Inc.VERVTroy ListerChiefDERIVJul 25DReturned to issuer32,000——0derivatives
Verve Therapeutics, Inc.VERVTroy ListerChiefDERIVJul 25DReturned to issuer6,630——0derivatives
Verve Therapeutics, Inc.VERVTroy ListerChiefDERIVJul 25DReturned to issuer12,075——0derivatives
Verve Therapeutics, Inc.VERVTroy ListerChiefDERIVJul 25DReturned to issuer40,000——0derivatives
Verve Therapeutics, Inc.VERVTroy ListerChiefDERIVJul 25DReturned to issuer225,000——0derivatives
Verve Therapeutics, Inc.VERVTroy ListerChiefJul 25UTender offer6,952——0
Verve Therapeutics, Inc.VERVTroy ListerChiefDERIVApr 1MPLANOption exercise4,025$0.00—?12,075derivatives
Verve Therapeutics, Inc.VERVTroy ListerChiefDERIVApr 1MPLANOption exercise3,315$0.00—?6,630derivatives
Verve Therapeutics, Inc.VERVTroy ListerChiefApr 2SPLAN2,189$4.15$9K6,952
Verve Therapeutics, Inc.VERVTroy ListerChiefApr 1MPLANOption exercise7,340——9,141
Verve Therapeutics, Inc.VERVTroy ListerChiefDERIVJan 8AAward40,000$0.00—?40,000derivatives
Verve Therapeutics, Inc.VERVTroy ListerChiefDERIVJan 8AAward225,000$0.00—?225,000derivatives